Danaher had a disappointing 2024. Its path to success next year goes through Wall Street

23 hours ago 5
ARTICLE AD BOX

A worker uses a machine made by Pall Corp. during a demonstration of the clarification stage of the production of influenza vaccine during a tour at a Sanofi Pasteur vaccine production facility in Swiftwater, Pennsylvania.

Stephen Hilger | Bloomberg | Getty Images

Life sciences firm Danaher has certainly not been an easy stock to own this year. A wave of startups going public on Wall Street would go a long ways toward changing that.

Read Entire Article